Literature DB >> 7308998

A peek at the Child-Turcotte classification.

H O Conn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7308998     DOI： 10.1002/hep.1840010617

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  33 in total

1.  Tizanidine-induced hypotension in patients with liver cirrhosis.

Authors:  Kenji Momo; Masato Homma; Makoto Abei; Ichinosuke Hyodo; Yukinao Kohda
Journal:  Eur J Clin Pharmacol       Date:  2008-06       Impact factor: 2.953

2.  Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding.

Authors:  D Patch; A Armonis; C Sabin; K Christopoulou; L Greenslade; A McCormick; R Dick; A K Burroughs
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

3.  Hyperfibrinolysis in hepatosplenic schistosomiasis.

Authors:  N E el-Bassiouni; A E el Bassiouny; H R el-Khayat; M M Akl; S A Omran
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

4.  Bacteremia and "Endotipsitis" following transjugular intrahepatic portosystemic shunting.

Authors:  Meir Mizrahi; Lilach Roemi; Daniel Shouval; Tomer Adar; Maya Korem; Alon Moses; Alan Bloom; Oren Shibolet
Journal:  World J Hepatol       Date:  2011-05-27

5.  Effects of total bilirubin on the prevalence of osteoporosis in postmenopausal women without potential liver disease.

Authors:  Lu-Qin Bian; Rong-Zhen Li; Zheng-Yun Zhang; Yan-Ji Jin; Hyung-Wook Kang; Zhen-Zhu Fang; Youn-Soo Park; Yoon-Ho Choi
Journal:  J Bone Miner Metab       Date:  2013-04-12       Impact factor: 2.626

Review 6.  Adequacy and support of physiological functions in the acutely ill cirrhotic patient.

Authors:  I Giovannini; G Boldrini; C Chiarla; M Castagneto; G Sganga; G Tramutola; F Caracciolo; G Castiglioni
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

Review 7.  Effects of liver disease on pharmacokinetics. An update.

Authors:  V Rodighiero
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

8.  Manipulation of ascitic fluid pressure in cirrhotics to optimize hemodynamic and renal function.

Authors:  J A Savino; T Cerabona; N Agarwal; D Byrne
Journal:  Ann Surg       Date:  1988-10       Impact factor: 12.969

9.  Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.

Authors:  Rocco Orlando; Pierpaolo Piccoli; Sara De Martin; Roberto Padrini; Pietro Palatini
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

10.  Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses.

Authors:  S D Ferrara; S Zotti; L Tedeschi; G Frison; F Castagna; L Gallimberti; G L Gessa; P Palatini
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.